Breaking News Instant updates and real-time market news.

ALXN

Alexion

$118.99

2.27 (1.94%)

07:34
12/22/16
12/22
07:34
12/22/16
07:34

Alexion failure adds to cautious sentiment, says Jefferies

Jefferies analyst Eun Yang says that while the Phase 3 study failure of Alexion's Soliris for prevention of delayed graft function after deceased donor kidney transplant is not meaningful to the valuation, it adds to the cautious sentiment on the shares. The analyst viewed trial as risky with a small market potential and did not include the indication in her estimates. She keeps a Hold rating on Alexion Pharmaceuticals with a $120 price target.

  • 21

    Feb

ALXN Alexion
$118.99

2.27 (1.94%)

12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Gilead buying Alexion tops Piper's potential events in 2017
Piper Jaffray healthcare analysts, led by Joshua Schimmer, laid out 17 potential surprise or provocative events for Biopharma in 2017. Their potential outcomes and events are led Gilead (GILD) acquiring Alexion (ALXN) and a President Donald Trump tweeting about the price of Biogen and Ionis Pharmaceuticals' (IONS) Spinraza. Other potential events Piper sees is a "massively dilutive" equity recapitalization for Valeant (VRX) and a failure for Seattle Genetics' (SGEN) ECHELON trial. The firm also sees the potential for Teva cleaning house and bringing in a non-Israeli CEO.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Overweight
Alexion trial failure 'not surprising or important,' says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says the Phase 3 study failure of Alexion's Soliris for prevention of delayed graft function after deceased donor kidney transplant is "not surprising or important." The analyst did not include the indication in his model after prior failures of Soliris in the transplant setting. Schimmer continues to believe 2017 will be a recovery year for Alexion. He keeps an Overweight rating on the shares. The stock is down $1.24 to $117.75 in after-hours trading.
12/22/16
FBCO
12/22/16
NO CHANGE
Target $160
FBCO
Outperform
Alexion's DGF trial failure not impactful to valuation, says Credit Suisse
Credit Suisse analyst Alethia Young said Alexion's trial failure of Phase 2/3 PROTECT results of Soliris in patients for the prevention of delayed graft function, or DGF, is a headline negative, but not impactful to valuation. Young said expectations were low into this trial and it was not factored into his valuation. The analyst rates shares an Outperform with a $160 price target, down from $165.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$75.82

1.97 (2.67%)

06:04
08/23/17
08/23
06:04
08/23/17
06:04
Hot Stocks
Lowe's CEO says 'pleased with our improved comparable sales performance' »

"We are pleased with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 21

    Nov

LOW

Lowe's

$75.82

1.97 (2.67%)

06:03
08/23/17
08/23
06:03
08/23/17
06:03
Earnings
Lowe's revises FY17 EPS view to $4.20-$4.30 from about $4.30, consensus $4.62 »

Backs FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 21

    Nov

GOOG

Alphabet

$924.69

18.03 (1.99%)

, GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

06:02
08/23/17
08/23
06:02
08/23/17
06:02
Periodicals
Google to announce specs for Titan security chip on Thursday, Reuters reports »

Google (GOOG) is expected…

GOOG

Alphabet

$924.69

18.03 (1.99%)

GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

AMZN

Amazon.com

$966.90

13.61 (1.43%)

MSFT

Microsoft

$73.16

1.01 (1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 05

    Sep

LOW

Lowe's

$75.82

1.97 (2.67%)

06:01
08/23/17
08/23
06:01
08/23/17
06:01
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 21

    Nov

LOW

Lowe's

$75.82

1.97 (2.67%)

06:00
08/23/17
08/23
06:00
08/23/17
06:00
Earnings
Lowe's reports Q2 adjusted EPS $1.57, consensus $1.61 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 21

    Nov

SPX

S&P 500

06:00
08/23/17
08/23
06:00
08/23/17
06:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$73.16

1.01 (1.40%)

05:59
08/23/17
08/23
05:59
08/23/17
05:59
Hot Stocks
Microsoft unveils Project Brainwave for real-time AI »

Microsoft engineer Doug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

GDX

Market Vector Gold Miners

$23.09

-0.22 (-0.94%)

05:57
08/23/17
08/23
05:57
08/23/17
05:57
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.21

-0.55 (-0.45%)

05:57
08/23/17
08/23
05:57
08/23/17
05:57
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRAM

Everspin Technologies

$15.22

0.3 (2.01%)

05:57
08/23/17
08/23
05:57
08/23/17
05:57
Hot Stocks
Everspin Technologies names Kevin Conley as CEO, effective September 1 »

Everspin Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

NUGT

Direxion Gold Miners Bull

$32.79

-0.86 (-2.56%)

05:57
08/23/17
08/23
05:57
08/23/17
05:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.22

-0.58 (-3.09%)

05:56
08/23/17
08/23
05:56
08/23/17
05:56
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$26.31

0.61 (2.37%)

05:56
08/23/17
08/23
05:56
08/23/17
05:56
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$60.10

1.74 (2.98%)

05:56
08/23/17
08/23
05:56
08/23/17
05:56
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$47.36

-3.72 (-7.28%)

05:55
08/23/17
08/23
05:55
08/23/17
05:55
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$82.37

5.27 (6.84%)

05:55
08/23/17
08/23
05:55
08/23/17
05:55
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$16.79

-2.75 (-14.07%)

05:54
08/23/17
08/23
05:54
08/23/17
05:54
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$78.87

5.4 (7.35%)

05:54
08/23/17
08/23
05:54
08/23/17
05:54
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$9.77

0.06 (0.62%)

05:54
08/23/17
08/23
05:54
08/23/17
05:54
Technical Analysis
United States Oil Fund: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$29.34

0.25 (0.86%)

05:53
08/23/17
08/23
05:53
08/23/17
05:53
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$25.16

0.58 (2.36%)

05:52
08/23/17
08/23
05:52
08/23/17
05:52
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$12.14

-0.29 (-2.33%)

05:52
08/23/17
08/23
05:52
08/23/17
05:52
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$39.33

0.58 (1.50%)

05:52
08/23/17
08/23
05:52
08/23/17
05:52
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$66.49

0.32 (0.48%)

05:51
08/23/17
08/23
05:51
08/23/17
05:51
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$37.02

0.17 (0.46%)

05:51
08/23/17
08/23
05:51
08/23/17
05:51
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.